reboxetine has been researched along with ADDH in 13 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 7 (53.85) | 29.6817 |
| 2010's | 5 (38.46) | 24.3611 |
| 2020's | 1 (7.69) | 2.80 |
| Authors | Studies |
|---|---|
| Hu, X; Li, W; Pan, L | 1 |
| Ghanizadeh, A | 1 |
| Buoli, M; Cahn, W; Serati, M | 1 |
| Arabgol, F; Hebrani, P; Panaghi, L | 1 |
| Alaghband-Rad, J; Riahi, F; Shahrivar, Z; Tehrani-Doost, M | 1 |
| Alamo, C; García-Campos, N; López-Muñoz, F; Loro, M; Quintero, J | 1 |
| Corbo, M; Fiori, F; Martinotti, G; Sepede, G | 1 |
| Bronstein, Y; Laor, N; Ratner, S; Toren, P; Weizman, A | 1 |
| Laor, N; Lerer-Amisar, D; Ratner, S; Toren, P; Weizman, A | 1 |
| Cak, HT; Cetin, FC | 1 |
| Ben-Amitay, G; Laor, N; Lask, M; Ratner, S; Toren, P; Weizman, A | 1 |
| Moallemi, S; Shahrivar, Z; Tehrani-Doost, M | 1 |
| Leckman, JF; Mercadante, MT; Otka, JE; Scahill, L | 1 |
4 review(s) available for reboxetine and ADDH
| Article | Year |
|---|---|
Meta-analysis on the efficacy of the norepinephrine reuptake inhibitors reboxetine and atomoxetine for the treatment of schizophrenia and attention deficit hyperactivity disorder.
Topics: Adrenergic Uptake Inhibitors; Atomoxetine Hydrochloride; Attention Deficit Disorder with Hyperactivity; Humans; Norepinephrine; Reboxetine; Schizophrenia; Treatment Outcome | 2023 |
A systematic review of reboxetine for treating patients with attention deficit hyperactivity disorder.
Topics: Adrenergic Uptake Inhibitors; Attention Deficit Disorder with Hyperactivity; Humans; Morpholines; Randomized Controlled Trials as Topic; Reboxetine; Treatment Outcome | 2015 |
Alternative pharmacological strategies for adult ADHD treatment: a systematic review.
Topics: Adrenergic alpha-Agonists; Adult; Amphetamines; Antidepressive Agents; Attention Deficit Disorder with Hyperactivity; Benzhydryl Compounds; Bridged Bicyclo Compounds, Heterocyclic; Bupropion; Central Nervous System Stimulants; Desipramine; Dopamine Agents; Droxidopa; Drug Combinations; Duloxetine Hydrochloride; Guanfacine; Histamine Agents; Humans; Lisdexamfetamine Dimesylate; Lithium Compounds; Lobeline; Mecamylamine; Memantine; Modafinil; Morpholines; Nicotinic Agonists; Nicotinic Antagonists; Nomifensine; Paroxetine; Pyridines; Pyridoxine; Pyrrolidonecarboxylic Acid; Quinazolinones; Reboxetine; Venlafaxine Hydrochloride; Wakefulness-Promoting Agents | 2016 |
Reboxetine in clinical practice: a review.
Topics: Antidepressive Agents; Attention Deficit Disorder with Hyperactivity; Depression; Humans; Morpholines; Reboxetine; Sleep Wake Disorders | 2012 |
6 trial(s) available for reboxetine and ADDH
| Article | Year |
|---|---|
Reboxetine versus methylphenidate in treatment of children and adolescents with attention deficit-hyperactivity disorder.
Topics: Adolescent; Adrenergic Uptake Inhibitors; Attention Deficit Disorder with Hyperactivity; Central Nervous System Stimulants; Child; Double-Blind Method; Female; Humans; Male; Methylphenidate; Morpholines; Reboxetine | 2009 |
Efficacy of reboxetine in adults with attention-deficit/hyperactivity disorder: a randomized, placebo-controlled clinical trial.
Topics: Adult; Antidepressive Agents; Attention Deficit Disorder with Hyperactivity; Double-Blind Method; Female; Humans; Male; Morpholines; Placebos; Psychiatric Status Rating Scales; Reboxetine; Treatment Outcome | 2010 |
Reboxetine for ADHD in children non-responders or with poor tolerance to methylphenidate: a prospective long-term open-label study.
Topics: Adolescent; Attention Deficit Disorder with Hyperactivity; Central Nervous System Stimulants; Child; Drug Resistance; Female; Humans; Male; Methylphenidate; Morpholines; Prospective Studies; Reboxetine; Severity of Illness Index | 2010 |
Six-week open-label reboxetine treatment in children and adolescents with attention-deficit/hyperactivity disorder.
Topics: Adolescent; Adrenergic Uptake Inhibitors; Attention Deficit and Disruptive Behavior Disorders; Attention Deficit Disorder with Hyperactivity; Child; Diagnostic and Statistical Manual of Mental Disorders; Double-Blind Method; Female; Humans; Male; Morpholines; Reboxetine | 2005 |
A possible antienuretic effect of reboxetine in children and adolescents with attention deficit/hyperactivity disorder: case series.
Topics: Adolescent; Analysis of Variance; Attention Deficit Disorder with Hyperactivity; Child; Enuresis; Female; Humans; Male; Morpholines; Reboxetine; Time Factors; Treatment Outcome | 2005 |
Reboxetine maintenance treatment in children with attention-deficit/hyperactivity disorder: a long-term follow-up study.
Topics: Adolescent; Adrenergic Uptake Inhibitors; Attention Deficit Disorder with Hyperactivity; Body Weight; Child; Electrocardiography; Female; Follow-Up Studies; Humans; Male; Morpholines; Parents; Psychiatric Status Rating Scales; Reboxetine; Severity of Illness Index; Suicide | 2007 |
3 other study(ies) available for reboxetine and ADDH
| Article | Year |
|---|---|
Reboxetine use in the treatment of attention-deficit/hyperactivity disorder.
Topics: Adolescent; Antidepressive Agents; Antidepressive Agents, Tricyclic; Attention Deficit Disorder with Hyperactivity; Central Nervous System Stimulants; Child; Female; Humans; Imipramine; Male; Methylphenidate; Morpholines; Reboxetine | 2006 |
An open-label trial of reboxetine in children and adolescents with attention-deficit/hyperactivity disorder.
Topics: Adolescent; Adrenergic Uptake Inhibitors; Attention Deficit Disorder with Hyperactivity; Child; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Humans; Male; Morpholines; Personality Assessment; Reboxetine; Treatment Outcome | 2008 |
Reboxetine as a potentially effective treatment for attention deficit hyperactivity disorder.
Topics: Adrenergic Uptake Inhibitors; Adult; Attention Deficit Disorder with Hyperactivity; Humans; Male; Morpholines; Reboxetine | 2001 |